Gliptadin Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

Serious adverse reactions including pancreatitis and hypersensitivity reactions have been reported. Hypoglycemia has been reported in combination with sulfonylurea (4.7%-13.8%) and insulin (9.6%). Tabulated list of adverse reactions are listed as follows (table) by system organ class and frequency. Frequencies are defined as: very common (>1/10); common (>1/100 to < 1/10); uncommon (>1/1,000 to < 1/100); rare (>1/10,000 to < 1/1,000); very rare (<1/10,000) and not known (cannot be estimated from the available data). (See table.)

Click on icon to see table/diagram/image

View ADR Monitoring Form

sitagliptin

Manufacturer:

Sai Mirra Innopharm

Distributor:

MedChoice Endocrine Group

Marketer:

MedChoice Endocrine Group